WHO ICTRP trial
Non alcoholic fatty liver disease and dark chocolate
IRCT201303264545N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201303264545N2 |
|---|---|
| Public title | Non alcoholic fatty liver disease and dark chocolate |
| Scientific title | Effect of dark chocolate on serum levels of liver enzymes, inflammation and oxidative stress status in patients with non alcoholic fatty liver disease |
| Primary sponsor | Research Institute for Infectious Diseases of Digestive System, Ahvaz Jundi Shapur University of Med |
| Secondary sponsors | Shirin Asal Co. |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Non alcoholic fatty liver. Non alcoholic fatty liver disease;Non alcoholic fatty liver disease |
| Interventions | Intervention 1: Intervention group: daily consumption of 30 grams dark chocolate 83% (made by Iran Shirin Asal Company) for 3 months. Intervention 2: Control group: without consuming dark chocolate for 3 months.;Treatment - Drugs;Treatment… |
| Registration date | Dec 25, 2014 |
| Target size | 42 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: